Literature DB >> 34716885

Proposing a novel care program: reminiscence therapy involved care for anxiety, depression, and quality of life in postoperative cervical cancer patients.

Xiaojing Liu1, Kun Yuan2, Xuekui Ye1, Rui Liu3.   

Abstract

BACKGROUND: Reminiscence therapy (RT) relieves mental disorders and improves quality of life (QoL) in some cancer survivors, but in postoperative cervical cancer patients, its effect is unclear. This study aimed to assess the impact of reminiscence therapy involved care (RTIC) and usual care (UC) on anxiety, depression, QoL, and survival in postoperative cervical cancer patients.
METHODS: In this randomized control study, 152 eligible postoperative cervical cancer patients were randomized as 1:1 ratio into RTIC (N = 76) and UC (N = 76) groups: the former received routine care and RT, while the latter only received routine care for 12 months. Anxiety, depression, and QoL were evaluated from baseline (month (M) 0) to M12, respectively. Patients were continuously followed up to M36 for overall survival (OS) calculation.
RESULTS: HADS-Anxiety score from M6 to M12 was decreased; both HADS-Depression score from M9 to M12 and depression rate at M12 were reduced in RTIC group compared with UC group (all P < 0.05). QLQ-C30 global health status score at M6 and M12, as well as QLQ-C30 function score at M12, was increased in RTIC group compared with UC group (all P < 0.05). However, QLQ-C30 symptom score at each visit and OS exhibited no difference between the two groups. From sub-group analysis, RTIC disclosed a distinct effect on patients whose age ≥ 50 years but not on those < 50 years.
CONCLUSION: RTIC reduces anxiety (partly) and depression and improves QoL in postoperative cervical cancer patients, especially in old patients.
© 2021. Royal Academy of Medicine in Ireland.

Entities:  

Keywords:  Anxiety; Cervical cancer; Depression; Quality of life; Reminiscence therapy involved care

Mesh:

Year:  2021        PMID: 34716885     DOI: 10.1007/s11845-021-02728-7

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   2.089


  22 in total

1.  [A long journey of cervical cancer prevention in China].

Authors:  Y L Qiao
Journal:  Zhonghua Zhong Liu Za Zhi       Date:  2018-10-23

2.  [Real-world research on cervical cancer screening program and effect evaluation for Chinese population].

Authors:  Y Q Zhao; Y Dai; L Dang; L H Kong; Y Zhang; R M Feng; Y L Qiao; J H Lang
Journal:  Zhonghua Zhong Liu Za Zhi       Date:  2018-10-23

Review 3.  Achieving cervical cancer elimination among Indigenous women.

Authors:  Lisa J Whop; Megan A Smith; Tamara L Butler; Anna Adcock; Karen Bartholomew; Marc T Goodman; Rachel L Winer; Elizabeth Milosevic; Beverley Lawton
Journal:  Prev Med       Date:  2021-03-04       Impact factor: 4.018

Review 4.  Neoadjuvant chemotherapy increases the 5-year overall survival of patients with resectable cervical cancer: A systematic review and meta-analysis.

Authors:  Yunbao Xu; Mengting Zhang; Jiaying Zhang; Derry Minyao Ng; Xiaoxiao Chen; Yuexiu Si; Yetan Shi; Xiangyuan Li; Danyi Mao; Lu Yang
Journal:  Taiwan J Obstet Gynecol       Date:  2021-05       Impact factor: 1.705

5.  Post-operative small pelvic intensity-modulated radiation therapy for early-stage cervical cancer with intermediate-risk factors: efficacy and toxicity.

Authors:  Guangyu Zhang; Fangfang He; Li Miao; Haijian Wu; Youzhong Zhang; Chunli Fu
Journal:  Jpn J Clin Oncol       Date:  2021-05-28       Impact factor: 3.019

6.  Cost-effectiveness of cervical cancer screening with human papillomavirus DNA testing and HPV-16,18 vaccination.

Authors:  Jeremy D Goldhaber-Fiebert; Natasha K Stout; Joshua A Salomon; Karen M Kuntz; Sue J Goldie
Journal:  J Natl Cancer Inst       Date:  2008-02-26       Impact factor: 13.506

7.  Should adjuvant chemotherapy be formally studied among patients found to have pelvic lymph node metastases following radical hysterectomy with lymphadenectomy for early-stage cervical cancer?

Authors:  Alyssa C Bujnak; Krishnansu S Tewari
Journal:  J Gynecol Oncol       Date:  2021-04-19       Impact factor: 4.401

8.  Cancer prevention: cervical cancer.

Authors:  Mamsau Ngoma; Philippe Autier
Journal:  Ecancermedicalscience       Date:  2019-07-25

9.  Early stage cervical cancer: psychosocial and sexual outcomes of treatment.

Authors:  A Cull; V J Cowie; D I Farquharson; J R Livingstone; G E Smart; R A Elton
Journal:  Br J Cancer       Date:  1993-12       Impact factor: 7.640

10.  The effect of digital reminiscence therapy on people with dementia: a pilot randomized controlled trial.

Authors:  SeolHwa Moon; Kyongok Park
Journal:  BMC Geriatr       Date:  2020-05-06       Impact factor: 3.921

View more
  2 in total

1.  Reminiscence therapy is a feasible care program for improving cognitive function, anxiety, and depression in recurrent acute ischemic stroke patients: a randomized, controlled study.

Authors:  Jiaying Yu; Yun Tang; Jingfeng Han; Jiawei Chen; Weiwei Lin; Wei Cui
Journal:  Ir J Med Sci       Date:  2022-07-27       Impact factor: 2.089

2.  Reminiscence Therapy as a Potential Method to Improve Psychological Health and Quality of Life in Elderly Hepatocellular Carcinoma Patients: A Randomized, Controlled Trial.

Authors:  Teng Li; Bin Li; Lu Tan; Bo Lv
Journal:  Front Surg       Date:  2022-08-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.